Delivery Order SPE2DB22D3011-SPE2DB24FP8YF
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,315.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This delivery order has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds a $999,999,999.00 indefinite delivery contract with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $10,170.76 award has a completion date of March 7, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products. The contract, valued at $1,578.00, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML medication and has a completion date of March 6, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical items to support military treatment programs and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The order has a potential value of $16,788.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that regularly provides pharmaceuticals and medical supplies to support U.S. government agencies,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $1,323.67, has an ultimate completion date of March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,400.00 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and has an active indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a...
- The Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,365.96, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, for the provision of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract, valued at $1,578.00, has a completion date of March 4, 2024 and was awarded on March 1, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, will deliver the pharmaceutical products to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The $1,160.72 firm fixed-price contract has an ultimate completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.0.5ML. The $13,469.22 delivery order has a completion date of February 1, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) valued up to...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP8YFDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $4,144.74 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, and no set-aside designation was used. Additionally, Amerisourcebergen Drug Corp holds an indefinite delivery contract with a potential value of up to $999,999,999.00 from DLA, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 1/31/24 |